Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05164380
Other study ID # Aphasia_ImageType_LangVariety
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 29, 2019
Est. completion date January 28, 2021

Study information

Verified date December 2021
Source University of Applied Sciences and Arts Northwestern Switzerland
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The observational study aims to investigate the effect of two factors that influence the ease with which aphasic and healthy participants name visual stimuli. The main factors investigated here are the image type of the visual stimulus (drawing or photographic image) and the response variety (standard language vs dialect). The hypothesis is formulated as follows: The image type of the visual stimulus (drawing or photographic image) and the response variety (standard language or dialect) will have an effect on naming correctness and/or naming latencies in people with aphasia within the picture naming test. The experiment was as follows: Persons with aphasia and healthy participants were presented with objects and verbs depicted as photographs or illustrations on a tablet. All participants were asked to name the depicted term in two different language varieties as correctly and as fast as possible. Answers were recorded synchronously. No feedback should be given to the participants (=no therapy). The results of picture naming were not analyzed patient-specifically in relation to their condition or therapy. Naming performance was collected as a momentary data set in order to investigate the speed of naming in general. The ethic committee Northwestern and Central Switzerland approved the study to be observational as no effect of intervention(s) on biomedical or other health related outcomes were evaluated, but only the influence of type of the visual stimulus and the response variety on correctness and naming latencies in the two participant groups.


Description:

Qulity assurance: To verify the presence and reliability of all subject data, the following items were checked during these visits using a checklist: Presence of informed consent, presence of all data requested in the questionnaire, correctness of the data copied from the source files (e.g. test protocols) and traceability of the data flow. At the end of the experiment, the correct storage of the data (informed consent of the study participants, identification list, raw data) were checked. All involved staff who had access to the clinical data were informed and trained about anonymization, ethical aspects and correct data manipulation and storage. Direct access to the source data and all relevant documents and records is guaranteed to the ethics committee upon request and presentation. Data dictionary: - Questionnaire on personal and health-related information of the experiment participants: Frequencies, descriptive statistics - The Pyramids and Palm Trees test (PPTT) (Howard & Patterson 1992): passed/not passed: scores above 90% indicate correct cognitive semantics, scores below indicate impaired; 90% of the images must be correctly matched, i.e., at least 47 of 52 items. - Colouring of Pictures test (CoPT) (De Renzi et al. 1972): passed/not passed: In order to exclude the presence of an acquired color diagnosis due to the brain injury suffered by participants with aphasia, the ability to assign colors to objects is tested with a coloration test. - Picture Naming Test: Number of correct responses and naming latencies when picture stimuli are presented in two language varieties (Swiss dialect and Swiss standard language) Data recording and source data: Case Report Forms (CRF) were printed out on paper and given to experiment participants and practice partners to collect personal and health-related data. Personal and health-related source data was collected in hard copy in the CRF and hard copies were given to study participants and practice partners. Data from pretesting (PPTT, CoPT) for experiment participants with aphasia were recorded manually on the CRF, as were any comments about abnormalities during the course of the study. Data needed for analysis of naming correctness and naming latency (audio and, if consent is given, video data) were collected electronically. Data on naming correctness were also collected on the CRF. The qualitative question-guided interview at the conclusion of data collection was recorded electronically, with accompanying key words noted on the CRF. AAT scores (from Aachener aphasia test scale) as well as other routinely collected data from patient records of participants with aphasia on the type of aphasia present was manually transferred to the CRF by the speech therapists of the collaborators. The CRFs in paper form are digitized by study staff by scanning and manually transferred to electronic data (filling in Excel lists). Data protection and data security: confidentiality and encryption The collection, transmission, storage and analysis of health-related personal data of this experiment was carried out in accordance with Art. 5 of the HFV (Humanforschungsgesetz) and in strict compliance with Swiss legal data protection regulations. The project data was kept strictly confidential and was only accessible to authorized personnel who needed the data to fulfill their tasks within the research project. All staff were informed about data protection and confidentiality and were subject to the legal requirements. In the CRF and other project-specific documents, participants were only referred to by a unique identification code, which could only be reconstructed by the participants themselves, but which did not allow any conclusions to be drawn about the participants. The participant identification list as well as the signed informed consents were stored in a secure location at the collaborators and was only transferred to the FHNW after the end of the study, where they will be kept in a safe. Participant data was collected using an application that was programmed for the experiment under the unique participant identification number only. Other relevant personal and health data was collected in paper form in the CRF. Audio recordings were made of study participants during the naming test and, with the consent of the study participants, they were also filmed; the image and audio sequence were stored in each case. The video recording data was only used for further research, education and training purposes with the prior consent of the experiment participants. All subject-related data was encrypted and stored on the tablet's SD card. The SD card was personally transported to the FHNW by the person conducting the study together with the CRF, where it was handed over to the study director. The information was then decrypted and analyzed on an FHNW computer. The decrypted data was stored securely on three external storage media. One was kept as a backup in the FHNW safe, and two others were used for data analysis at the Academy of Art and Design FHNW and at the School of Education FHNW. These external hard drives were kept securely in safes at the respective institutes when not in use. No original data was stored directly on the FHNW computers. Only the results of the data analysis were stored on other personal computers or secured internal servers. The encryption was managed by the project management. Only a few authorized persons know the key. A list is kept of these persons. Storage of data: Data obtained from the research project (raw data sets, analysis results, and anonymized documents) will be archived for at least ten years, protected from access, to ensure scientific sustainability. One hard drive is kept in the FHNW safe, one in appropriately secure locations at the IVK (HGK) and ISP (PH) institutes of the FHNW. Only authorized persons have access. Participant identification lists are destroyed. Should the data be destroyed after a minimum of ten years, all electronic data is deleted and the storage area is securely overwritten. Paper sheets such as the CRF are rendered unusable with the file shredder. Sample size assessment: Determining the sample size: The power analysis is based on a simulation. A baseline accuracy (e.g., the percentage correct on stimulus type 1, variety 1) for each of the n virtual participants was first defined.A certain effect size for each of the two factors, stimulus and variety was defined. Both factors are assumed to have an effect as large as an odds ratio of 1.3. This size of odds ratio was used to define the odds for each participant and thus the precision in the other cells of the design. Both effects are analyzed for each simulated data set and then analyzed using a generalized linear mixed-effects model (GLMM) with a binomial distribution of outcomes and a random intercept per participant. Power is calculated as the proportion of simulations for which this statistical model detects an effect of both stimulus type and response variety. Plan for missing data: Only those data sets in which participants have completed at least two cells of the design (stimulus type x response variety) are included in the analysis. To counteract dropout of experiment participants - caused by withdrawal of experiment participants, by technical problems in data collection, or by insufficiently collected data - more participants are preemptively recruited than statistically necessary (40 instead of 36 subjects per group) to ensure that there will be enough data to represent an effect, should there be one. Statistical analysis: The proportion of correct responses in each cell of the design (stimulus type x response variety) is analyzed using a generalized linear mixed regression model with a binomial distribution of outcomes, including a random intercept estimated for each participant.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date January 28, 2021
Est. primary completion date January 28, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Inclusion Criteria PWA - Diagnosed with minimal, light or moderate aphasia provoked by a left hemisphere cardiovascular accident - post-acute or chronic phase with a minimum of six weeks post onset - Swiss German as first language - sufficient language comprehension to follow the instructions during the experiment - attention span of minimum 45 minutes - no indication for dementia and if any only mild dysarthria and apraxia of speech according to the treating speech therapist - intact color vision - normal or corrected to normal vision and hearing Inclusion Criteria CG - Swiss German as first language - No neurological diseases in their health history - Intact color vision - Normal or corrected to normal vision and hearing Exclusion Criteria: Exclusion Criteria PWA - Not fulfilling the above inclusion criteria - Severe aphasia - Aphasia with an associated disorder in the area of access to semantic object information, as indicated by performance on The Pyramids and Palm Trees Test (PPTT) Exclusion Criteria CG -Not fulfilling the above inclusion criteria

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Picture naming tasks
PWA and CG had to name 128 pictures presented on a tablet, in addition to 8 trial images.

Locations

Country Name City State
Switzerland Kantonsspital Aarau Aarau
Switzerland Logo Treffpunkt Altdorf
Switzerland Praxis LogoTreffpunkt Altdorf
Switzerland Kantonsspital Baden Baden
Switzerland Felix Platter Spital Basel
Switzerland REHAB Basel Basel
Switzerland Kantonsspital Baselland Liestal
Switzerland Fachhochschule Nordwestschweiz Muttenz
Switzerland Rundum Therapie Oberwil
Switzerland Kantonsspital Olten Olten
Switzerland Praxis für Logopädie Pratteln
Switzerland Reha Rheinfelden Rheinfelden
Switzerland Spitäler Schaffhausen Schaffhausen
Switzerland Privat Klinik im Park Schinznach Schinznach Bad
Switzerland Rundum Therapie Therwil
Switzerland Spital Zofingen Zofingen
Switzerland Logopädische Praxis Dietiker Zürich
Switzerland Praxis Unterstrass Zürich
Switzerland Stadtspital Waid Zürich
Switzerland Universitätsspital Zürich Zürich

Sponsors (1)

Lead Sponsor Collaborator
Simone Hemm-Ode

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Naming correctness The degree of correctness or incorrectness of the responses was coded manually following defined criteria. Response of the naming task was considered correct if the participant provided exclusively the previously defined reaction to the stimuli within 10 seconds. To be defined as extended correct response the reaction had to be classified as a synonym or a diminutive of the requested term. Responses describing a generic concept (e.g. "dog" instead of "poodle"), providing too much specification (e.g. rain coat instead of coat) were accounted as extended correct. The same applied for plural forms given instead of singulars. Data were assessed during picture naming test on the test day (upto 1 month after inclusion).
Primary Naming latencies Naming latencies were only calculated for correct responses. Each naming latency was calculated as an interval by measuring the onset of correct target response following after the onset of visual naming stimulus on the tablet screen. Naming latencies were manually measured through using the speech analysis program Praat (Boersma, 2001), which allows acoustic analysis by presenting waveform and spectrogram of audio data.
Limit: 999 characters.
Data were assessed during picture naming test on the test day (upto 1 month after inclusion).
See also
  Status Clinical Trial Phase
Completed NCT03622411 - Tablet-based Aphasia Therapy in the Chronic Phase N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Recruiting NCT03929432 - Treatment Outcomes With tDCS in Post-Stroke Aphasia N/A
Completed NCT03662295 - Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
Completed NCT03679637 - Tablet-based Aphasia Therapy in the Acute Phase After Stroke N/A
Completed NCT03228264 - A Trial Investigating Telerehabilitation as an add-on to Face-to-face Speech and Language Therapy in Post-stroke Aphasia. N/A
Completed NCT03550092 - Analysis of Brain Activity to Uncover Brain-behavior Relationships Related to Therapy Outcomes in Aphasia N/A
Suspended NCT04290988 - Circuitry Assessment and Reinforcement Training Effects on Recovery N/A
Recruiting NCT05969548 - pBFS-guided cTBS at Different Doses for Aphasia After Stroke N/A
Recruiting NCT04138940 - Modulating Intensity and Dosage of Aphasia Scripts N/A
Terminated NCT02249819 - Evaluating Anodal tDCS Preceding Aphasia Therapy Phase 1/Phase 2
Completed NCT01654029 - Patient Centred Communication Intervention N/A
Completed NCT00843427 - fMRI of Language Recovery Following Stroke in Adults N/A
Active, not recruiting NCT00227461 - Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients. Phase 1
Completed NCT03773419 - Improving Electronic Written Communication in Aphasia N/A
Not yet recruiting NCT04142866 - Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia N/A
Suspended NCT04048668 - tDCS to Treat Subacute Aphasia N/A
Recruiting NCT04081207 - Using Augmentative & Alternative Communication to Promote Language Recovery for People With Post-Stroke Aphasia N/A
Completed NCT02226796 - Transcranial Direct Stimulation (tDCS) and Behavioral Intervention in Aphasia N/A
Completed NCT01163461 - Phonomotor Treatment of Word Retrieval Deficits in Individuals With Aphasia N/A